TTK Healthcare (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
TTK Healthcare Limited |
|||
|
Price: ₹1,435.65 | ||
| 52 Week Low: ₹1,310.15 52 Week High: ₹1,893.95 |
|||
| Market Capital: 2,091.43 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—General | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: TTK Healthcare Share Price Target For 2024
- 1.1.1: TTK Healthcare Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: TTK Healthcare Share Price Target For 2025
- 1.2.1: TTK Healthcare Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: TTK Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: TTK Healthcare Brief Company Overview
- 4: TTK Healthcare Financial Performance
- 4.0.1: Is TTK Healthcare A Good Buy For Long Term?
To predict the TTK Healthcare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
TTK Healthcare Share Price Target For 2024
The line chart displays the monthly closing prices of TTK Healthcare with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for TTK Healthcare shares in 2024, see the table below.
TTK Healthcare Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 1500.1 (+4.48%) | Price Action: 10 Dec 2024 Low |
| 2024 Target 2 | 1482.44 (+3.25%) | Price Action: 27 Nov 2024 High |
| 2024 Target 1 | 1465.09 (+2.04%) | Price Action: 21 Nov 2024 High |
| Current Price | 1435.65 | TTK Healthcare's share price as of 23 Dec 2024 |
| Stop Loss 1 | 1423.69 (-0.84%) | Price Action: Chart |
| Stop Loss 2 | 1405.08 (-2.13%) | Price Action: Jul 2024 Low |
| Stop Loss 3 | 1383.99 (-3.6%) | Price Action: Feb 2018 High |
Short-Term Technical Outlook
Current Technical Position: TTK Healthcare is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹1488.34 serves as the nearest technical reference point.
Historical Returns: 3-month: -13.75% | 6-month: -1.14% | 1-year: +2.56%
TTK Healthcare Share Price Target For 2025
The line chart displays the monthly closing prices of TTK Healthcare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for TTK Healthcare shares in 2025, see the table below.
TTK Healthcare Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1873.63 (+30.5%) | Price Action: Chart |
| 2025 Target 2 | 1838.69 (+28.07%) | Price Action: Chart |
| 2025 Target 1 | 1820.49 (+26.8%) | Fibonacci Extension Level 64.90% |
| Current Price | 1435.65 | TTK Healthcare's share price as of 23 Dec 2024 |
| Stop Loss 1 | 1327.63 (-7.53%) | Price Action: Jul 2023 High |
| Stop Loss 2 | 1311.74 (-8.64%) | Price Action: Dec 2023 Low |
| Stop Loss 3 | 1290.88 (-10.09%) | Price Action: May 2023 High |
Long-Term Technical Outlook
52-Week Range Analysis: TTK Healthcare is currently trading near its 52-week low of ₹1310.15, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: +2.56% | 3-year: +109.76% | 5-year: +213.38%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
TTK Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,435.65 | ||
| 2024 | ₹1,732.59 | +20.68% | ₹1,758.58 |
| 2025 | ₹1,663.49 | -3.98% | ₹1,761.75 |
| 2026 | ₹1,733.42 | +4.2% | ₹1,890.31 |
| 2027 | ₹1,902.75 | +9.76% | ₹2,018.87 |
| 2028 | ₹2,147.43 | +12.85% | ₹2,179.64 |
| 2029 | ₹2,245.81 | +4.58% | ₹2,279.50 |
| 2030 | ₹2,128.69 | -5.21% | ₹2,275.99 |
| 2031 | ₹2,192.50 | +2.99% | ₹2,404.55 |
| 2032 | ₹2,381.32 | +8.61% | ₹2,533.11 |
| 2033 | ₹2,661.68 | +11.77% | ₹2,701.61 |
| 2034 | ₹2,759.04 | +3.65% | ₹2,800.43 |
| 2035 | ₹2,593.89 | -5.98% | ₹2,790.24 |
| 2036 | ₹2,651.58 | +2.22% | ₹2,918.80 |
| 2037 | ₹2,859.90 | +7.85% | ₹3,047.36 |
| 2038 | ₹3,175.92 | +11.05% | ₹3,223.56 |
| 2039 | ₹3,101.90 | -2.33% | ₹3,148.43 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
TTK Healthcare Brief Company Overview
TTK Healthcare Limited: A Comprehensive Overview Established in 1928, TTK Healthcare Limited is a leading player in the healthcare industry in India, with a diverse product portfolio and a strong reputation. Key Products and Services: Animal welfare products (feed supplements,...
antibiotics, antiparasiticides) Consumer products (baby care, personal care, home care, sexual wellness products) Medical devices (artificial heart valves, orthopedic implants) Protective devices (male contraceptives) Food products (papads, cereals, pulses) Maps and atlases TTK Healthcare is committed to providing high-quality products and services to meet the evolving needs of the healthcare industry.TTK Healthcare Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 2,091.43 Crore | Market valuation of TTK Healthcare's shares. |
| Revenue (TTM) | 751.87 Crore | Total revenue generated by TTK Healthcare over the past twelve months. |
| Net Income (TTM) | +64.98 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +1.1% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +8.18% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+0.7% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+7.5% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
2.56 | Company's total debt divided by total shareholder equity. |
| Total Debt | 24.89 Crore | Sum of TTK Healthcare's current & long-term financial obligations. |
| Total Cash | 844.96 Crore | Total amount of liquid funds available to TTK Healthcare. |
| Beta | 0.63 | Beta is less than 1 indicating that the TTK Healthcare's price is less volatile than the market. |
Is TTK Healthcare A Good Buy For Long Term?
TTK Healthcare is a good buy for the long term. The company has a strong financial position with a low debt-to-equity ratio and ample cash reserves. Its revenue and earnings have been growing steadily over the past year, and its profit margin is healthy. The company's stock price has also performed well in recent years, delivering strong returns to investors.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
